85 related articles for article (PubMed ID: 1284544)
1. Observations on the interleukin-6 and acute phase protein profiles in the disease course of patients with lupus erythematosus.
Swaak AJ; Sintnicolaas C; Meijer C; Smeenk RT
Lupus; 1992 May; 1(3):151-5. PubMed ID: 1284544
[TBL] [Abstract][Full Text] [Related]
2. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus.
Meijer C; Huysen V; Smeenk RT; Swaak AJ
Lupus; 1993 Dec; 2(6):359-65. PubMed ID: 7511020
[TBL] [Abstract][Full Text] [Related]
3. Selected acute phase proteins and interleukin-6 in systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Pochopień-Kenig G; Scieszka J
Autoimmunity; 2007 May; 40(3):217-22. PubMed ID: 17453721
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus.
Swaak AJ; van Rooyen A; Aarden LA
Rheumatol Int; 1989; 8(6):263-8. PubMed ID: 2471249
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins.
Lacki JK; Samborski W; Mackiewicz SH
Clin Rheumatol; 1997 May; 16(3):275-8. PubMed ID: 9184265
[TBL] [Abstract][Full Text] [Related]
6. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
9. Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.
Lacki JK; Leszczynski P; Kelemen J; Müller W; Mackiewicz SH
J Med; 1997; 28(1-2):99-107. PubMed ID: 9249616
[TBL] [Abstract][Full Text] [Related]
10. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
11. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
Enocsson H; Sjöwall C; Kastbom A; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329
[TBL] [Abstract][Full Text] [Related]
12. Studies of serum C-reactive protein in systemic lupus erythematosus.
Williams RC; Harmon ME; Burlingame R; Du Clos TW
J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.
Firooz N; Albert DA; Wallace DJ; Ishimori M; Berel D; Weisman MH
Lupus; 2011 May; 20(6):588-97. PubMed ID: 21436216
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders.
Stuart RA; Littlewood AJ; Maddison PJ; Hall ND
Clin Exp Rheumatol; 1995; 13(1):17-22. PubMed ID: 7774098
[TBL] [Abstract][Full Text] [Related]
15. Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus.
Metsärinne KP; Nordström DC; Konttinen YT; Teppo AM; Fyhrquist FY
Rheumatol Int; 1992; 12(3):93-6. PubMed ID: 1384103
[TBL] [Abstract][Full Text] [Related]
16. [The changes of serum levels of interleukin-6 and interleukin-8 in pregnant women with systemic lupus erythematosus].
Su Y; Hong S; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):660-2. PubMed ID: 11930690
[TBL] [Abstract][Full Text] [Related]
17. The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.
da Silva AE; dos Reis-Neto ET; da Silva NP; Sato EI
Lupus; 2013 Dec; 22(14):1479-83. PubMed ID: 24135080
[TBL] [Abstract][Full Text] [Related]
18. Serum and urinary interleukin-6 in systemic lupus erythematosus.
Peterson E; Robertson AD; Emlen W
Lupus; 1996 Dec; 5(6):571-5. PubMed ID: 9116699
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?
Capper ER; Maskill JK; Gordon C; Blakemore AI
Clin Exp Immunol; 2004 Nov; 138(2):348-56. PubMed ID: 15498048
[TBL] [Abstract][Full Text] [Related]
20. [Levels of acute-phase-reactants in patient with dermatomysitis and its correlations with IL-6 and dermatomyositis disease activity].
Yang M; Liang Y; Cai YF; Lin H; Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):814-7. PubMed ID: 24325119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
